Laboratory findings and biomarkers in long COVID: what do we know so far? Insights into epidemiology, pathogenesis, therapeutic perspectives and challenges

D Tsilingiris, NG Vallianou, I Karampela… - International Journal of …, 2023 - mdpi.com
Long COVID (LC) encompasses a constellation of long-term symptoms experienced by at
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …

COVID-19 and Long COVID: Disruption of the Neurovascular Unit, Blood-Brain Barrier, and Tight Junctions

D Kempuraj, KK Aenlle, J Cohen… - The …, 2023 - journals.sagepub.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), could affect brain structure and function. SARS-CoV …

Hippocampal subfield abnormalities and biomarkers of pathologic brain changes: from SARS-CoV-2 acute infection to post-COVID syndrome

M Díez-Cirarda, M Yus-Fuertes, R Sanchez-Sanchez… - …, 2023 - thelancet.com
Background Cognitive deficits are among the main disabling symptoms in COVID-19
patients and post-COVID syndrome (PCS). Within brain regions, the hippocampus, a key …

Blood markers show neural consequences of longCOVID-19

N Tang, T Kido, J Shi, E McCafferty, JM Ford, K Dal Bon… - Cells, 2024 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persists throughout the
world with over 65 million registered cases of survivors with post-COVID-19 sequelae, also …

[HTML][HTML] Neurological manifestations of post-acute sequelae of COVID-19: which liquid biomarker should we use?

D Comeau, M Martin, GA Robichaud… - Frontiers in …, 2023 - frontiersin.org
Long COVID syndrome, also known as post-acute sequelae of COVID-19 (PASC), is
characterized by persistent symptoms lasting 3–12 weeks post SARS-CoV-2 infection …

COVID-19 biomarkers at the crossroad between patient stratification and targeted therapy: the role of validated and proposed parameters

M Rizzi, D D'Onghia, S Tonello, R Minisini… - International Journal of …, 2023 - mdpi.com
Clinical knowledge about SARS-CoV-2 infection mechanisms and COVID-19
pathophysiology have enormously increased during the pandemic. Nevertheless, because …

Increase in gut permeability and oxidized ldl is associated with post-acute sequelae of SARS-CoV-2

C Mouchati, JC Durieux, SN Zisis, D Labbato… - Frontiers in …, 2023 - frontiersin.org
Background Post-acute sequelae of SARS-CoV-2 (PASC) is marked by persistent or newly
developing symptoms beyond 4 weeks of infection. Investigating gut integrity, oxidized lipids …

Long COVID or Post-COVID-19 Condition: Past, Present and Future Research Directions

C Fernández-de-Las-Peñas, AV Raveendran… - Microorganisms, 2023 - mdpi.com
The presence of symptoms after an acute SARS-CoV-2 infection (long-COVID) has become
a worldwide healthcare emergency but remains underestimated and undertreated due to a …

Characterizing long-COVID brain fog: A retrospective cohort study

GY Lam, RW Damant, G Ferrara, RK Lim… - Journal of …, 2023 - Springer
Background Long COVID or post-COVID condition (PCC) is a common complication
following acute COVID-19 infection. PCC is a multi-systems disease with neurocognitive …

Promising Markers of Inflammatory and Gut Dysbiosis in Patients with Post-COVID-19 Syndrome

E Sorokina, A Pautova, O Fatuev… - Journal of Personalized …, 2023 - mdpi.com
Post-COVID-19 syndrome is a complex of different symptoms, which results in a
multisystemic impairment after the suffering from COVID-19 infection. The aim of the study …